View More Recent Stories
-
Lexicon Pharma (LXRX) Tops Q2 EPS by 1c
-
Piper Sandler Reiterates Overweight Rating on Lexicon Pharmaceuticals (LXRX)
-
Lexicon Pharma (LXRX) Receives December 20, 2024 PDUFA Goal Date for Sotagliflozin Type 1 Diabetes NDA Resubmission
-
H.C. Wainwright Starts Lexicon Pharmaceuticals (LXRX) at Buy


